The Right Drug for the Right Patient: Navigating Systemic Therapy Options in Metastatic Renal Cell Carcinoma and Future Directions

被引：2
作者：
Choueiri, Toni K. [1 ,2 ,3 ,4 ,5 ,6 ]
Motzer, Robert J. [7 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02215 USA
[2] Brigham & Womens Hosp, Kidney Canc Ctr, Boston, MA 02115 USA
[3] DF HCC, Kidney Canc Program, Boston, MA USA
[4] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
[5] Kidney Canc Assoc, Med & Sci Steering Comm, Evanston, IL USA
[6] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
[7] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2015年 / 13卷 / 10期
关键词：
SUNITINIB;
D O I：
10.6004/jnccn.2015.0145
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1168 / 1170
页数：3
相关论文
共 15 条
[1]  
Albiges L, 2015, GENITOURIURINARY CAN
[2]  
[Anonymous], 2014, J CLIN ONCOL, DOI 10.1200/jco.2014.32.15_suppl.5012
[3]   A phase I study of cabozantinib (XL184) in patients with renal cell cancer [J].
Choueiri, T. K. ;
Pal, S. K. ;
McDermott, D. F. ;
Morrissey, S. ;
Ferguson, K. C. ;
Holland, J. ;
Kaelin, W. G. ;
Dutcher, J. P. .
ANNALS OF ONCOLOGY, 2014, 25 (08) :1603-1608
[4]  
Hammers HJ, 2014, ASCO M, V32, P4504, DOI DOI 10.1200/JC0.2014.32.15_
[5]   PD-1 Blockade in Renal Cell Carcinoma: To Equilibrium and Beyond [J].
Harshman, Lauren C. ;
Drake, Charles G. ;
Choueiri, Toni K. .
CANCER IMMUNOLOGY RESEARCH, 2014, 2 (12) :1132-1141
[6]  
Hudes GR, 2011, J NATL COMPR CANC NE, V9, pS1
[7]   Alternate sunitinib schedules in patients with metastatic renal cell carcinoma [J].
Kalra, S. ;
Rini, B. I. ;
Jonasch, E. .
ANNALS OF ONCOLOGY, 2015, 26 (07) :1300-1304
[8]   Novel chromosome copy number changes to predict clinical response to sunitinib in patients with advanced renal cell carcinoma. [J].
Lee, Chung-Han ;
Motzer, Robert ;
Hoetker, Andreas ;
Akin, Oguz ;
Molina, Ana M. ;
Gold, Theresa Margaret ;
Patil, Sujata ;
Gowrishankar, Banumathy ;
Houldsworth, Jane .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[9]  
McDermott DF, 2014, ANN ONCOL, V25
[10]   Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab [J].
McDermott, David F. ;
Drake, Charles G. ;
Sznol, Mario ;
Choueiri, Toni K. ;
Powderly, John D. ;
Smith, David C. ;
Brahmer, Julie R. ;
Carvajal, Richard D. ;
Hammers, Hans J. ;
Puzanov, Igor ;
Hodi, F. Stephen ;
Kluger, Harriet M. ;
Topalian, Suzanne L. ;
Pardoll, Drew M. ;
Wigginton, Jon M. ;
Kollia, Georgia D. ;
Gupta, Ashok ;
McDonald, Dan ;
Sankar, Vindira ;
Sosman, Jeffrey A. ;
Atkins, Michael B. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (18) :2013-U42
12